Register
Forgot your password?

The new aspects of etiopathogenesis of erectile dysfunction as a predictor of cardiovascular pathology

Authors: Boсkeria O.L., Goryacheva T.S.

Company: A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation; Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

For correspondence:  Sign in or register.

Type:  Stable ischemic heart disease


DOI: https://doi.org/10.15275/kreatkard.2016.02.05

For citation: Bockeria O.L., Goryacheva T.S. The new aspects of etiopathogenesis of erectile dysfunction as a predictor of cardiovascular pathology. Kreativnaya Kardiologiya. 2016; 10 (2): 150-160 (in Russian)

Keywords: erectile dysfunction cardiovascular diseases coronary heart disease endothelial dysfunction

Download
Full text:  

 

Abstract

The erectile dysfunction has a leading position in the structure of sexual disorders both in frequency of occurrence and social importance, because it worsens the quality of life of the most socially active males. Inability of sexual function for various reasons can lead to the development of neurosis and disturbs the social adaptation.

Nowadays the erectile dysfunction is a key element in understanding the mechanisms of development and progression of cardiovascular diseases. Increasing number of patients with risk factors of heart diseases associates with the growth of the sexual disorders. The modern science searches the new opportunities of diagnosis the “silent” cardiac pathology. The oxidative stress, atherosclerosis and endothelial dysfunction are the keys of the formation of both erectile dysfunction and heart diseases. It is proved that the clinical manifestations of systemic atherosclerosis are directly correlated with a diameter of the arteries. In high risk patients of atherosclerosis, first manifest symptoms of erectile dysfunction due to the smaller diameter of the cavernous arteries in comparison to the coronary arteries, can be the first sigh of future coronary atherosclerosis. The simple fact of correlation of erectile function and the cardiovascular system, the existence of common mechanisms and risk factors raises new questions about the safe and effective methods of correction the sexual disorders. Now this problem stimulates continuity and collegiality between the physicians of different specialties. The physician should consider the patient's age, weight, duration of erectile dysfunction and the presence of risk factors by Framingham when deciding which patients with erectile dysfunction should be clinically evaluated by cardiovascular diseases and the possibility of its occurrence. The erectile dysfunction is a barometer not only of the man's health but the vessels as well.

References

  1. NIH Consensus development panel on impotence: NIH Consensus conference. JAMA. 1993; 270 (1): 83–90.
  2. Ansong K.S., Lewis C., Jenkins P., Bell J. Epidemiology of erectile dysfunction: a community-based study in rural New York State. Ann. Epidemiol. 2000; 10 (5): 293–6.
  3. Brock G. Diagnosing erectile dysfunction could save your patient's life. Can. Urol. Assoc. J. 2014; 8 (7–8): S. 151–2.
  4. Dong J.Y., Zhang Y.H., Qin L.Q. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J. Am. Coll. Cardiol. 2011; 58: 1378–85.
  5. Bohm M., Baumhakel M., Teo K. et al. ONTARGET/ TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/ TRANSCEND). Trials. Circulation. 2010; 121: 1439–46.
  6. Hirata Н., Kawamoto К., Kikuno N. et. al. Restoring erectile function by antioxidant therapy in diabetic rats. J. Urol. 2009; 182: 251–63.
  7. Khotsanyan Ch.V., Golukhova E.Z.Erectile dysfunc-tion as an early predictor of ischemic heart disease.Kreativnaya kardiologiya. 2016; 10 (1): 39–42(in Russian).
  8. Nehra A., Jackson G., Miner M. et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin. Proc. 2012; 87: 766–78.
  9. Rodriguez J.J., Al Dashti R., Schwarz E.R. Linking erectile dysfunction and coronary artery disease. Int. J. Impot. Res. 2005; 17 (1): 12–8.
  10. Conti G., Virag R. Human penile erection and organic importance: normal histology and histopathology. Urol. Int. 1989; 44 (5): 303–8.
  11. Vlachopoulos C., Ioakeimidis N., Terentes-Printzios D., Stefanadis C. The triad erectile dysfunctionendothelial dysfunction-cardiovascular disease. Curr. Pharm. Des. 2008; 14: 3700–14.
  12. Chiurlia E., D'Amico R., Ratti C., Granata A.R. et al. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J. Am. Coll. Cardiol. 2005; 46: 1503–6.
  13. Solomon H., Man J.W., Wierzbicki A.S., Jackson G. Relation of erectile dysfunction and angiographic coronary artery disease. Am. J. Cardiol. 2003; 91: 230–1.
  14. Meller S.M., Stilp E., Walker Ch.N. et al. The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. J. Inv. Cardiol. 2013; 25 (6): 313–9.
  15. Montorsi P., Ravagnani P.M., Galli S., Salonia A. et al. Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur. Urol. 2006; 50: 721–31.
  16. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010; 55: 1318–27.
  17. Kaiser D.R., Billups K., Mason C., Wetterling R. et al. Impaired brachial artery endothelium-dependent and independent vasodilation in men with erectile dysfunction and no other clinical cardiovascualr disease. J. Am. Coll. Cardiol. 2004; 43: 179–80.
  18. Kratz M.T., Schumacher H., Sliwa K. et al. Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients. Eur. J. Prevent. Cardiol. 2014; 21 (3): 272–80.
  19. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS. Med. 2006; 3 (11): 442.
  20. Chazov E.I.Coronary heart disease and the possi-bility of increasing the effectiveness of its treatment. Coronary heart disease: materials forum. 2000; 2–5(in Russian)
  21. Oganov R.G., Maslennikova G.Ya. Development ofpreventive cardiology in Russia. Kardiovaskulyarnayaterapiya i profilaktika. 2004; 3 (1): 11–4 (in Russian).
  22. Chobanian A.V., Bakris G.L., Black H.R. et al. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42 (6): 1206–52.
  23. Chew K.K., Finn J., Stuckey B., Gibson N. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linkeddata study. J. Sex. Med. 2010; 7 (1) (Pt. 1): 192–202.
  24. Seftel A.D., Sun P., Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J. Urol. 2004; 171 (6) (Рt. 1): 2341–5.
  25. Walczak M.K., Lokhandwala N., Hodge M.B., Guay A.T. Prevalence of cardiovascular risk factors in erectile dysfunction. J. Gend. Specif. Med. 2002; 5 (6): 19–24.
  26. Vertkin A.L.Erectile dysfunction in the practice ofa cardiologist. In: Erectile dysfunction, diagnosisand treatment. Moscow: Praktika; 2004: 82–96(in Russian).
  27. Kloner R.A., Mullin S.H., Shook T., Matthews R. et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J. Urol. 2003; 170: 46–50.
  28. Roumeguére T., Wespes E., Carpentier Y., Hoffmann P. et al. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur. Urol. 2003; 44: 355–9.
  29. Selvin E., Burnett A.L., Platz E.A. Prevalence and risk factors for erectile dysfunction in the US. Am. J. Med. 2007; 120 (2): 151–7.
  30. Sasayama S., Ishii N., Ishikura F., Kamijima G. et al. Men's health study – epidemiology of erectile dysfunction and cardiovascular disease. Circ. J. 2003; 67: 656–9.
  31. Montorsi P., Ravagnani P.M., Galli S., Rotatori F. et al. Association between erectile dysfunction and coronary artery disease: role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur. Heart. J. 2006; 27: 2632–9.
  32. Montorsi F., Briganti A., Salonia A., Rigatti P. et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur. Urol. 2003; 44: 360–5.
  33. Hodges L.D., Kirby M., Solanki J., O'Donnell J. et al. The temporal relationship between erectile dysfunction and cardiovascular disease. Int. J. Clin. Pract. 2007; 61: 2019–25.
  34. Thomson I.M., Tangem C.M., Goodman P.J., Probstfield J.L. et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005; 294: 2996–3002.
  35. Gazzaruso C., Solerte S.B., Pujia A., Coppola A. et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 2008; 51: 2040–4.
  36. Chew K.K., Finn J., Stuckey B., Gibson N. et al. Erectile dysfunction as a predictor of subsequent atherosclerotic cardiovascular events: findings from a linkeddata study. J. Sex. Med. 2010; 7 (1) (Pt. 1): 192–202.
  37. Speel T.G., van Langen H., Meuleman E.J. The risk of coronary heart disease in men with erectile dysfunction. Eur. Urol. 2003; 44: 366–71.
  38. Ponholzer A., Gutjahr G., Temml C., Madersbacher S. Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire. Int. J. Impot. Res. 2010; 22: 25–9.
  39. Ma R.C., So W.Y., Yang X., Yu L.W. et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J. Am. Coll. Cardiol. 2008; 51: 2045–50.
  40. Salem S., Abdi S., Mehrsai A., Saboury B. et al. Erectile dysfunction severity as a risk predictor for coronary artery disease. J. Sex. Med. 2009; 6: 3425–32.
  41. Inman B.A., Sauver J.L., Jacobson D.J., McGree M.E. et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin. Proc. 2009; 84: 108–13.
  42. Greenstein A., Chen J., Miller H., Matzkin H. et al. Does severity of ischemic coronary disease correlate with erectile function? Int. J. Impot. Res. 2007; 9 (3): 123–6.
  43. Jackson G., Boon N., Eardley I., Kirby M. et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int. J. Clin. Pract. 2010; 64: 848–57.
  44. Araujo A.B., Hall S.A., Ganz P., Chiu G.R. et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J. Am. Coll. Cardiol. 2010; 55: 350–6.
  45. Hotaling J.M., Walsh T.J., Macleod L.C. et al. Erectile dysfunction is not independently associated with cardiovascular death: data from the Vitamins and Lifestyle (VITAL) study. J. Sex. Med. 2012; DOI: 10.1111/j.1743-6109.2012.02826.x.
  46. Bokeria O.L., Goryacheva T.S.A new view on theproblem of erectile dysfunction in patients with atrialfibrillation. Annaly aritmologii.2016; 13 (1): 38–46.DOI: 10.15275/annaritmol.2016.1.5.

About Authors

  • Bockeria Ol'ga Leonidovna, MD, DM, Professor, Chief Research Associate, Deputy Chief of Department;
  • Goryacheva Tamara Sergeevna, Urologist.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by